Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Large-scale testing (Phase 3)Study completedNCT04770220
What this trial is testing

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Who this might be right for
Early Alzheimer's Disease
Alzheon Inc. 325
Testing effectiveness (Phase 2)Study completedNCT01782495
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 129
Large-scale testing (Phase 3)WithdrawnNCT01447394
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770984
What this trial is testing

Treatment of CKD Patients With HCV

Who this might be right for
HCV Infection ( Genotype 4) in CKD Patients
Tanta University 50
Large-scale testing (Phase 3)Study completedNCT02642432
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis
AbbVie 146
Testing effectiveness (Phase 2)Study completedNCT01713283
What this trial is testing

Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 60
Post-approval studies (Phase 4)Study completedNCT00412334
What this trial is testing

SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 104
Testing effectiveness (Phase 2)Study completedNCT01958281
What this trial is testing

Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency

Who this might be right for
HCV Infection
Gilead Sciences 38
Post-approval studies (Phase 4)Ended earlyNCT01606800
What this trial is testing

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Large-scale testing (Phase 3)Study completedNCT02483156
What this trial is testing

Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis c
Egyptian Liver Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01725542
What this trial is testing

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Who this might be right for
HCV-HIV Co-Infection
ANRS, Emerging Infectious Diseases 75
Testing effectiveness (Phase 2)Study completedNCT01858766
What this trial is testing

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 379
Testing effectiveness (Phase 2)Study completedNCT03036839
What this trial is testing

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 95
Large-scale testing (Phase 3)UnknownNCT01653236
What this trial is testing

Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection

Who this might be right for
Genotype 4 Chronic Hepatitis C Infection
Theodor Bilharz Research Institute 40
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Large-scale testing (Phase 3)Study completedNCT02487199
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 18
Post-approval studies (Phase 4)Study completedNCT00502099
What this trial is testing

Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C
Amr Hafez 217
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Next Page